Loading...

2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2025

June 23 - 25, 2025 | ExCeL London, UK

EP.1398

Optimal Obstetric Management in Extreme Preterm Births: A Retrospective Cohort Study

Part of Topic

Intrapartum care

Optimal Obstetric Management in Extreme Preterm Births: A Retrospective Study

Daniel Tan, Imrana Butt, Mira Chainrai, Jacqueline Bamfo, Saadia Waheed

 

INTRODUCTION

Advancements in neonatal medical management over the past five years has

significantly increased the numbers of foetuses being considered for delivery.

Despite increasing knowledge in neonatal management post-birth, less is known

regarding optimal obstetric management for mothers who undergo preterm (22-

25+6 weeks) births.2 To further expand this knowledge base, we conducted a

literature search and retrospective study within Luton and Dunstable Hospital, UK

to identify key obstetric management and clinical practices that can improve

maternal and neonatal outcomes. These findings will guide future instances of

extreme preterm delivery.

 

METHODS

1. Literature search

Aim: To identify current guidelines in obstetric management of mothers with extreme preterm delivery

Sample size: 23/139 papers collected met inclusion criteria.

Main Conclusions:

i) Usefulness of antibiotics in preterm premature rupture of membranes (PPROM) cases3

ii) benefits of antenatal steroids, tocolytics and magnesium sulfate (MgSO4)3

iii) Suggested effectiveness of cervical clerage4 and amnioinfusion5. iv) divided opinions about delivery type3

 

2. Retrospective study

Aim: To analyse how different obstetric management methods performed at Luton and Dunstable Hospital, UK affect maternal or neonatal outcomes

Sample size: 93 patients (01/2020-01/2025), singleton pregnancies gestational age 22 weeks to 25+6 weeks

Statistics: Simple univariate and multivariate logistic regression models

 

RESULTS

Fig 1: Maternal complications remained low in our study, with 24.7% of women experiencing PPH, 12.9% requiring blood transfusions and there were zero

ICU or VTE incidences reported. Neonatal mortality was 47.3%, with high rates of respiratory distress (84.9%), intraventricular haemorrhage / IVH (51.6%)

and eventual developmental concerns (41.9%).

 

As expected, gestation age was strongly associated with lower neonatal morbidity and higher birth weight (+120g per additional week, P<0.0001). Intrapartum

antibiotics, steroids and MgSO₄ and gestational age had strong protective effects in univariate analysis but significant reduction in neonatal mortality after covariates

were accounted for only in MgSO₄ (p=0.011). Fig 2 shows the adjusted odds ratio (OR) and adjusted coefficients for key predictors. Interestingly caesarean section

seems to improve birth weight outcomes, but normal vaginal delivery seems to reduce birth weight in our adjusted model.

 

 

 

CONCLUSIONS + LIMITATIONS

1. In our dataset we found that only MgSO₄ seems to have a significant effect on neonatal survivability while other measures like steroids, antibiotics and gestational age had positive effects on univariate analysis but not with multivariate analysis. This highlights prevalence of confounding

and indication bias within our data, small sample size and single centre study.

2. Gestational age improves neonatal birth weight significantly in line with current literature6 but not significantly with infant mortality after multivariate analysis. Caesarean sections seem to improve birth weight over vaginal delivery which may add to current literature but should be treated

cautiously. No obvious obstetric management variable seemed to improve maternal outcomes, compounded by the minimal complications in the data.

3. We also failed to investigate the prolongation of gestation age (ie cervical clerage/tocolytics). Nonetheless this study adds support to current guidelines and further data, or meta-analysis is needed to observe more significant trends in improving maternal and neonatal outcomes.

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.